ALFA FinderBSE filing, NSE: BIJHANS. Summary written from the filing by ALFA Finder's alert engine.
Arvaya Healthcare Ltd: key numbers
- Share price
- ₹107.00
- Market cap
- ₹513.8 Cr
- Revenue (annual)
- ₹9.11 Cr
- Net profit (annual)
- ₹0.70 Cr
- P/E (TTM)
- 333.4×Sector 47.0×
- Promoter holding
- 28.33%-2.29% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Arvaya Healthcare Ltd
All →Arvaya Healthcare Capital Structure Change
Arvaya Healthcare's board approved the draft letter of offer for a rights issue of partly paid-up equity shares up to ₹210 Crore, plus a postal ballot. The board outcome's main decision is the rights issue, so it is classified as a capital raise step.
- Value
- ₹210.0 Cr
Arvaya Healthcare Acquisition
Arvaya Healthcare completed the acquisition of 100% equity in Sushodha Institute of Gastroenterology Private Limited on 1 November 2026. The target is now a wholly-owned subsidiary, with no consideration amount disclosed.
Arvaya Healthcare Other Announcement
Arvaya Healthcare filed its quarterly shareholding pattern under Regulation 31(1)(c). The filing reports routine ownership breakdowns with no transaction.
Arvaya Healthcare Board Meeting Date
Arvaya Healthcare schedules a 4 November 2026 board meeting on rights issue, draft letter of offer and related party transactions. Agenda items remain proposed only.
Arvaya Healthcare Preferential Issue
Director Bidari Kotresh Anilkumar acquired 591,129 Arvaya Healthcare shares through a preferential offer. Holding rises to 4.45% from 3.58%.
Arvaya Healthcare Preferential Issue
Arvaya Healthcare allotted 38,71,854 equity shares at Rs.40 each to 47 SIGPL shareholders in a share swap. The allotment is valued at Rs.15.49 Crore.
- Value
- ₹15.49 Cr
Other board meeting date announcements
All →Aspire & Innovative Advertising Board Meeting Date
Aspire & Innovative Advertising scheduled a November 14, 2026 board meeting to consider unaudited standalone results for the half year ended September 30, 2026. No results figures are attached yet.
SI Capital & Financial Services Board Meeting Date
S.I. Capital will hold a board meeting on 12 November 2026 to consider unaudited standalone quarterly results. This is a prior intimation for the meeting.
Axel Polymers Board Meeting Date
Axel Polymers will hold a board meeting on 13 November 2026 to consider unaudited half-year results. The trading window stays closed until 48 hours after results.
FlySBS Aviation Board Meeting Date
FlySBS Aviation has scheduled a board meeting for 11 November 2026 to consider unaudited half-yearly results for the period ended September 2026. The trading window is not closed.
Shri Krishna Devcon Board Meeting Date
Shri Krishna Devcon informs BSE of a board meeting on 14 November 2026 to consider quarterly and half-year unaudited results. The trading window stays closed until 48 hours after results are declared.
Cian Healthcare Board Meeting Date
Cian Healthcare intimated that its board will meet on November 13, 2026, to consider unaudited standalone and consolidated results for the half year ended September 30, 2026. The trading window closes from October 1 until 48 hours after the results.